ciprofloxacin-hydrocortisone otic and metoprolol succinate oral

ciprofloxacin-hydrocortisone otic increases levels of metoprolol succinate oral by decreasing metabolism. Ciprofloxacin may increase metoprolol plasma concentrations however mechanism is unknown. Further clinical evidence is needed but it may be appropriate to monitor patients during concomitant therapy with ciprofloxacin.

metoprolol succinate oral and ciprofloxacin-hydrocortisone otic

metoprolol succinate oral increases levels of ciprofloxacin-hydrocortisone otic by decreasing metabolism. Ciprofloxacin may increase metoprolol plasma concentrations however mechanism is unknown. Further clinical evidence is needed but it may be appropriate to monitor patients during concomitant therapy with ciprofloxacin.

Significant

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.